Perhaps I should have added SammyGriff that the use of the kits for detection and monitoring of bladder cancer represents a major change in medical practice for this purpose. As a consequence the trials in the US, represented by this announcement, have been going on for a very considerable time. The potential use of the kits is very substantial and the announcement therefore represents a potentially major income stream for CDY (and therefore, soon presumably, for Lyramid).
poorinvestor
Kaiser Permanente, page-25
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
